DeEtte Gray reports 4,465 RSU grants and October 1 disposals for CACI

Q: What did DeEtte Gray report on the CACI Form 4?

The Form 4 reports stock awards and transactions dated 10/01/2025 , including grants of 2,233 performance RSUs and 2,232 restricted stock units, and several dispositions.

Q: How many new equity awards did the Form 4 disclose for CACI?

The filing discloses two new award grants totaling 4,465 units on 10/01/2025 ( 2,233 PRSUs and 2,232 RSUs).

Q: Were any shares sold and at what price according to the Form 4?

Yes; the Form 4 records dispositions on 10/01/2025 , with some transactions executed at a reported price of $515.16 .

Q: Who signed the Form 4 and when?

The Form 4 was signed by DeEtte Gray on 10/03/2025 .

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

DeEtte Gray, President, US Operations of CACI, reported transactions dated 10/01/2025 on a Form 4. The filing shows multiple restricted stock unit and performance restricted stock unit grants and vesting events: prior grants from 10/01/2022, 10/01/2023, and 10/01/2024 are described, and new grants on 10/01/2025 include 2,233 performance RSUs and 2,232 restricted stock units. The Form 4 also records a series of non-derivative transactions on the same date including dispositions executed at a reported price of $515.16. The tables list changing beneficial ownership totals after each reported event for CACI common stock. The signature date on the form is 10/03/2025.

Positive

2,233 performance restricted stock units granted on 10/01/2025
2,232 restricted stock units granted on 10/01/2025
Prior grants from 10/01/2022, 10/01/2023, and 10/01/2024 are documented with vesting schedules

Negative

Multiple dispositions of CACI common stock were reported on 10/01/2025
Several sales were executed at a reported price of $515.16, reducing direct beneficial holdings after those trades

Insights

TL;DR: New equity awards and vesting activity totaling 4,465 units granted on 10/01/2025.

The filing documents two new grants on 10/01/2025: 2,233 performance restricted stock units and 2,232 restricted stock units. These awards are disclosed as subject to three-year vesting or performance-based vesting where noted.

This matters for compensation expense recognition and future dilution modelling because these awards will convert to CACI common stock if vesting conditions are met; the filing explicitly ties each award to underlying common shares.

TL;DR: Multiple reported disposals occurred on 10/01/2025, some executed at $515.16.

The Form 4 lists several transaction codes showing dispositions of CACI common stock on 10/01/2025, with specific sales recorded at $515.16. The report shows resulting beneficial ownership balances after each transaction.

From a disclosure and compliance perspective, the report meets Section 16 formatting by showing acquisitions, dispositions, and resulting ownership; all items are explicitly dated and signed on 10/03/2025.

10/03/2025 - 04:22 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Gray DeEtte

(Last)

(First)

(Middle)

TWO RESTON OVERLOOK

12021 SUNSET HILLS ROAD

(Street)

RESTON

20190

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
CACI INTERNATIONAL INC /DE/ [ CACI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President, US Operations

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
CACI Common Stock	10/01/2025		M		894	A	⁽¹⁾	30,560	D
CACI Common Stock	10/01/2025		F		404	D	$515.16	30,156	D
CACI Common Stock	10/01/2025		M		1,062	A	⁽²⁾	31,218	D
CACI Common Stock	10/01/2025		F		479	D	$515.16	30,739	D
CACI Common Stock	10/01/2025		M		659	A	⁽³⁾	31,398	D
CACI Common Stock	10/01/2025		F		298	D	$515.16	31,100	D
CACI Common Stock	10/01/2025		M		4,120	A	⁽⁴⁾	35,220	D
CACI Common Stock	10/01/2025		F		1,859	D	$515.16	33,361	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Performance Restricted Stock Units	⁽⁵⁾	10/01/2025		A		2,233		⁽⁵⁾	⁽⁵⁾	CACI Common Stock	2,233	⁽⁵⁾	2,233	D
Restricted Stock Units	⁽⁶⁾	10/01/2025		A		2,232		⁽⁶⁾	⁽⁶⁾	CACI Common Stock	2,232	⁽⁶⁾	2,232	D
Restricted Stock Units	⁽¹⁾	10/01/2025		M			894	⁽¹⁾	⁽¹⁾	CACI Common Stock	894	⁽¹⁾	0	D
Restricted Stock Units	⁽³⁾	10/01/2025		M			659	⁽³⁾	⁽³⁾	CACI Common Stock	659	⁽³⁾	1,319	D
Restricted Stock Units	⁽²⁾	10/01/2025		M			1,062	⁽²⁾	⁽²⁾	CACI Common Stock	1,062	⁽²⁾	1,062	D
Performance Restricted Stock Units	⁽⁴⁾	10/01/2025		M			4,120	⁽⁴⁾	⁽⁴⁾	CACI Common Stock	4,120	⁽⁴⁾	0	D

Explanation of Responses:

1. On October 1, 2022, Ms. Gray was granted 2,681 restricted stock units. These restricted stock units vest 1/3 per year for three years.

2. On October 1, 2023, Ms. Gray was granted 3,185 restricted stock units. These restricted stock units will vest 1/3 per year for three years.

3. On October 1, 2024, Ms. Gray was granted 1,978 restricted stock units. These restricted stock units will vest 1/3 per year for three years.

4. On October 1, 2022, Ms. Gray was granted 2,682 performance restricted stock units. These PRSU's vested on the third anniversary of the grant date based on the achievement of a three-year performance measure.

5. On October 1, 2025, Ms. Gray was granted 2,233 performance restricted stock units. The PRSU's will vest on the third anniversary of the grant date based on the achievement of a three-year performance measure.

6. On October 1, 2025, Ms. Gray was granted 2,232 restricted stock units. These restricted stock units will vest 1/3 per year for three years

Remarks:

	DeEtte Gray	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did DeEtte Gray report on the CACI Form 4?

The Form 4 reports stock awards and transactions dated 10/01/2025, including grants of 2,233 performance RSUs and 2,232 restricted stock units, and several dispositions.

How many new equity awards did the Form 4 disclose for CACI?

The filing discloses two new award grants totaling 4,465 units on 10/01/2025 (2,233 PRSUs and 2,232 RSUs).

Were any shares sold and at what price according to the Form 4?

Yes; the Form 4 records dispositions on 10/01/2025, with some transactions executed at a reported price of $515.16.

What vesting terms are disclosed for the awards?

The filing states prior RSU grants vest one-third per year over three years; PRSUs vest on the third anniversary based on a three-year performance measure where specified.

Who signed the Form 4 and when?

The Form 4 was signed by DeEtte Gray on 10/03/2025.

DeEtte Gray reports 4,465 RSU grants and October 1 disposals for CACI